Assessment of eosinophil granule proteins in various body fluids: Is there a relation to clinical variables in childhood asthma?

Clinical and Experimental Allergy

Volumn 29, Issue 6, 1999, Pages 786-793

  Koller, D Y ^a,b   Halmerbauer, G ^b   Frischer, T ^b   Roithner, B ^b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b NONE

Author keywords

Bronchial asthma; Bronchial hyperreactivity; Eosinophil cationic protein; Eosinophil protein X; Nasal lavage fluid; Pulmonary function; Serum; Urine

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; LUNG FUNCTION; MALE; NOSE MUCUS; PRIORITY JOURNAL;

ADULT; ASTHMA; BLOOD PROTEINS; BODY FLUIDS; CHILD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IRRIGATION; MALE; MAXIMAL EXPIRATORY FLOW RATE; NASAL CAVITY; RIBONUCLEASES;

EID: 0033001627     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00546.x     Document Type: Article

References (28)

1. 1 Kay AB. Eosinophils and asthma. N Engl J Med 1991; 324:1514-7.
2. 2 Reid LM, Gleich GJ, Hogg J, Kleinerman J, Laitinen LA. Pathology. In: Holgate ST, Howell JBL, Burney PGJ et al., eds. The Role of Inflammatory Processes in Airway Hyperresponsiveness. Oxford: Blackwell Scientific Publications, 1989: 36-79.
3. 3 Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992; 145:1477-83.
4. 4 Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123:2925-7.
5. 5 Wardlaw AJ, Dunette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage fluid in mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
6. 6 Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic activation in asthma. N Engl J Med 1990; 323:1033-9.
7. 7 Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
8. 8 Laitinen LA, Laitinen A, Heino M, Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991; 143:423-7.
9. 9 Rak S, Björnson A, Håkansson L et al. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991; 88:878-88.
10. 10 Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986; 39:177-253.
11. 11 Koller DY, Urbanek R, Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995; 152:629-33.
12. 12 Zimmermann B, Enander I, Zimmermann R, Ahlstedt S. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms. Clin Exp Allergy 1994; 24:149-55.
13. 13 Koller DY, Herouy Y, Götz M, Hagel E, Urbanek R, Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995; 73:413-7.
14. 14 Kristjanson S, Strannegård IL, Strannegård Ö, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma. A useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996; 97:1179-87.
15. 15 Lugosi E, Halmerbauer G, Frischer T, Koller DY. Urinary eosinophil protein X in relation to disease activity in childhood asthma. Allergy 1997; 52:765-9.
16. 16 Ingram JM, Rakes GP, Hoover GE, Platts-Mills TAE, Heymann PW. Eosinophil cationic protein in serum and in nasal washes from wheezing infants and children. J Pediatr 1995; 127:558-64.
17. 17 Wojnarowski C, Studnicka M, Kühr J, et al. Determinants of eosinophil cationic protein in nasal lavages in children. Clin Exp Allergy 1998; 28:300-5.
18. 18 Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991; 21:561-7.
19. 19 Carlson M, Hakånsson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophil and neutrophils in increased in asthma. J Allergy Clin Immunol 1991; 87: 27-33.
20. 20 American Thoracic Society. Standardization of spirometry 1987 update. Am Rev Respir Dis 1987; 2:1285-98.
21. 21 Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Methods, reference values. Prog Respir Res 1987; 22:113-218.
22. 22 Österreichische Gesellschaft für Lungenerkrankungen und Tuberkulose. Arbeitsgemeinschaft für klinische Atemphysiologie. Empfehlungen zu Standardisierung der inhalativen Provokation zur Messung der unspezifischen bronchialen Hyperreaktivität. Prax Klin Pneumol 1986; 40:356-64.
23. 23 Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity, and late-phase asthmatic reaction. Clin Allergy 1985; 15:411-8.
24. 24 Koller DY, Wojnarowski C, Herkner KR et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997; 99:752-6.
25. 25 Koller DY, Götz M, Eichler I, Urbanck R. Eosinophilic activation in cystic fibrosis. Thorax 1994; 49:496-9.
26. 26 Prat J, Xaubet A, Mullol J, Plaza V, Picado C. Cell content and albumin concentrations in nasal lavage from patients with rhinitis. Ann Allergy 1993; 70:175-8.
27. 27 Murray AB, Ferguson AC, Morrison B. Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1984; 68:119-24.
28. 28 Clough JB, Williams JD, Holgate ST. Profile of bronchial responsiveness in children with respiratory symptoms. Arch Dis Child 1992; 67:574-9.